deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT02498665

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

A Phase I Clinical Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Sponsor: Sumitomo Pharma America, Inc.

Conditions Acute Myeloid Leukemia Glioblastoma Multiforme Melanoma Myelodysplastic Syndromes Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Renal Cell Carcinoma Sarcoma
Interventions DSP-7888 Dosing Emulsion
Updated 13 times since 2017 Last updated: Nov 13, 2023 Started: Nov 30, 2015 Primary completion: Aug 31, 2018 Completion: Sep 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Acute Myeloid Leukemia and Glioblastoma Multiforme, this trial is completed. The trial is conducted by Sumitomo Pharma America, Inc. and has accumulated 13 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Sep 2019 · 11 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Nov 2023 · 18 months · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Nov 2023 — Dec 2023 [monthly]

    Completed PHASE1

  5. May 2022 — Nov 2023 [monthly]

    Completed PHASE1

▶ Show 8 earlier versions

  1. Jan 2021 — May 2022 [monthly]

    Completed PHASE1

  2. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE1

  3. Sep 2019 — Aug 2020 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Oct 2018 — Sep 2019 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE1

  6. Nov 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  7. Feb 2017 — Nov 2017 [monthly]

    Recruiting PHASE1

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sumitomo Pharma America, Inc.
Data source: Sumitomo Pharma America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations